Question 1

What are the potential benefits of tomotherapy compared to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

Question 4

What is the timeline for treatment and follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with the use of magnetic resonance spectroscopy in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

Question 6

How does this treatment fit into my overall cancer care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer clinical trial (NCT00126802). Contact the study team or your healthcare provider for specific answers.

What this study is about